Melanoma Institute Australia celebrates International Women's Day
8 March 2017
To celebrate International Women's Day, we're sharing how some of the women who inspire the way we work every day, are showing their commitment to accelerate gender parity.
Meet Danielle Fischer, our Science Communications Specialist.
"I wanted my career to make a difference to people, and I always had a passion for science, so studying Medical Science at uni was the obvious choice. After a few years working in the lab, I decided I enjoyed talking about research rather than actually doing it! And so by accident, I stumbled into Science Communications – a field I never knew existed while studying. It’s the perfect mix for me and I enjoy translating complex medical research for the general public to appreciate. I particularly like translating research that gives hope to patients."
This is Tuba Nur Gide, PhD student and winner of NSW National Council of Women Australia Day Award for her research focused on the role of immunotherapies in melanoma.
"My parents raised me to work hard, be independent and do well academically – they value education very highly. I think that’s why even as a little girl, I knew that I wanted to pursue completing a PhD, in whatever field of study I would end up choosing.
Having been awarded a PhD Scholarship from MIA two years in a row now is an opportunity that I am truly humbled by. Knowing people close to me that have been affected by cancer drives me even further to do the very best that I can.
I believe that it’s really important for females to have equal opportunity. All women should be valued as individuals. We’re strong, we’re smart and no one should push us around. Careers shouldn’t be defined by your gender and I hope that in the future, education opportunities offered to young boys and girls are free of gender bias or sexism.”
Maria Gonzalez, Clinical Trials Manager here at MIA.
"I completed an undergraduate degree in nursing at The University of Sydney and further postgraduate studies in health science. I am fortunate to have accessed training and education which has enabled me to pursue a career combining both cancer care and clinical research.
Women make up about 90% of Australia’s nursing workforce and play a pivotal role in clinical care and research. Today I will be bold and celebrate the valuable contribution and achievements of all nurses in the fight against cancer."
Clinicians and their patients now have access to three online risk calculators developed by researchers at Melanoma Institute Australia.
MIA's Co-Medical Director Professor Richard Scolyer has received The University of Sydney Alumni Award for International Achievement.
More than 120 MIA clinicians, researchers and staff came together online to share research highlights.
For the 2nd consecutive year, MIA's Co-Medical Director Professor Richard Scolyer has been selected in the top 100 best, brightest, and most powerful advocates of pathology by The Pathologist.
As of Monday 27th July all patients and carers/family members coming into The Poche Centre will be required to bring their own mask.
In a recent issue of Cancer Cell journal, Prof Georgina Long AO and Prof Richard Scolyer discuss the challenge of bringing together clinical work and scientific research to underpin successful cancer research.
Clinicians around the world now have access to a new online calculator that predicts the risk that a patient’s primary melanoma has spread to nearby lymph nodes.
Professor Long has been appointed as an Officer (AO) of the Order of Australia (General Division) for distinguished service to medicine, particularly, to melanoma clinical and translational research, and to professional medical societies.
“I had a complete response within about six months. All of my tumours disappeared."
‘We are extremely proud of our ongoing contribution to the global effort to save lives from melanoma, with Dr Silva’s prestigious award proof that we continue to lead the way,'
MIA's Co-Medical Director, Professor Richard Scolyer, has achieved a Google Scholar h-index of 100.
We know what Melanoma March means to our community, so when we had to cancel our physical events, we created Melanoma March Virtual so that everyone across Australia could still connect to honour loved ones and support each other.
A must-read personal account by Garry Maddox in The Sydney Morning Herald of how immunotherapy is revolutionising melanoma treatment.
On Friday, a publication that lays out the steps needed to find out if a systematic screening program for melanoma would benefit all Australians was published in the Australia & New Zealand Journal of Public Health.
Melanoma March events have been cancelled. A Virtual March will be held on Sunday 29th March. Read this statement from MIA CEO Matthew Browne.
Thank you to the thousands of Aussies who bought ‘Game On Mole‘ t-shirts, took selfies, shared t-shirt pics on social media and started lifesaving conversations around sun safety and skin health.
Melanoma patients now have greater access to subsidised immunotherapy thanks to additional treatments today being listed on the PBS.
Brisbane couple Leon and Tamra Betts were, like thousands of others around Australia, on the couch watching MAFS when newlywed Natasha ran through her weekly beauty routine. When they heard the 26-year-old mention solarium use, they were shocked, and then saddened, prompting this open letter to all young Australians.
Professor Richard Scolyer, Co-Medical Director of Melanoma Institute Australia, will welcome international attendees this weekend to a sold-out, two-day course on ‘Pigmented Lesions and Other Hot Topics in Dermatopathology’.
It is time for a reality check on solariums.
They have no place in anyone’s beauty routine.